HEALTH● LOW21h ago · Sep 1, 2026, 4:45 AM
Eli Lilly diabetes drug Mounjaro approved to reduce cardiovascular risks
businesstoday.in · India · global
The diabetes drug Mounjaro, developed by Eli Lilly, has been approved for its ability to reduce cardiovascular risks. This represents a significant advancement in treating diabetes and related heart conditions.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH26m agoBlood Bank of Delmarva Blood Drivewmdt.com · United StatesHEALTH41m agoJapan’s deadliest delicacy is getting more dangerousSouth China Morning PostHEALTH56m agoWhat it like to live with – and lose – a loved one with CTEwcvb.com · United StatesHEALTH1h agoAfrica grows more tobacco, spends more on imported cigarettes — WHOVanguard Nigeria